Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.

Kickingerede P, Brugnara G, Hansen MB, et al. Radiology. 2020;200978

Our unique biomarkers were used in a study to evaluate the effectiveness of the bevacizumab treatment.

Get full access to the article doi:

Click Here

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
© 2024 Cercare Medical. All rights reserved.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.
Perfusion Summit 2026
Date: 26 March 2026, Thursday
Time: 10:15 - 17:40 (CET)
Venue: Concorde Hall, Hilton Paris Hotel, CDG
Participation is Optional

Hands-On Workshops
Date: 27 March 2026

Workshop selection is optional and does not confirm registration. Confirmation and further details will be provided in January 2026. Please note that seating is limited.
By participating in this event, you consent to the use of your image, voice, and likeness in photographs, and videos for promotional purposes, in accordance with GDPR regulations.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)



    Request a demo

    Let us give you a tour around our solution.

    Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.



      })